In vitro studies using human hepatoma cells have linked negative expression of AKR1D1 to Nonalcoholic fatty liver disease (NAFLD) (Nikolaou et al., 2019). This evidence concerns the gene AKR1D1 and metabolic dysfunction-associated steatotic liver disease.